Drawing from recent successes in cancer immunotherapy, this Perspective discusses that effective cancer-nanomedicine therapies can be designed to prime antitumour immunity far from the site of disease.
- Wen Jiang
- Christina A. von Roemeling
- Betty Y. S. Kim